• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALMA LASERS LTD ALMA LIPOFLOW SYSTEM; LIPOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALMA LASERS LTD ALMA LIPOFLOW SYSTEM; LIPOPLASTY Back to Search Results
Model Number 1
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Breast Mass (2439)
Date of Event 09/11/2020
Type of Reportable Event Serious Injury
Event or Problem Description
A routine mammogram performed found a small unidentified mass present on the left breast not previously present in previous mammograms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALMA LIPOFLOW SYSTEM
Common Device Name
LIPOPLASTY
Manufacturer (Section D)
ALMA LASERS LTD
18 haharash street
caesarea, ha zafon 30798 95
IS  3079895
MDR Report Key11828822
Report Number3004450661-2021-00005
Device Sequence Number19875549
Product Code MUU
UDI-Device Identifier17290110121447
UDI-Public17290110121447
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 05/04/2021
Report Date (Section F) 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number1
Device Catalogue NumberAALP24091503
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date04/04/2021
Event Location Outpatient Treatment Facility
Date Report to Manufacturer04/26/2021
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/14/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age48 YR
Date Report Sent to FDA05/04/2021
-
-